Rapid сommunication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB)
World Health Organization. (2018). Rapid сommunication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). World Health Organization. http://www.who.int/iris/handle/10665/275383. License: CC BY-NC-SA 3.0 IGO
Gov't Doc #WHO/CDS/TB/2018.18
MetadataShow full item record
Showing items related by title and MeSH subject.
Regional Collaborating Committee on Tuberculosis Control and Care (RCC–TB). Third meeting Copenhagen, Denmark, 24 November 2014 Unknown author (2015)The third meeting of the Regional Collaborating Committee on Tuberculosis Care and Control (RCC-TB) steering group was held in Copenhagen, Denmark on 24 November 2014, with the participation of members and observers, including representatives from WHO country offices in the Region. This report briefly summarizes outputs from the presentations, discussion and working group sessions, and indicates future action.
Tuberculose à bacilles multirésistants et tuberculose à bacilles ultrarésistants dans la Région africaine : analyse de situation, enjeux et perspectives : rapport du Directeur régional Comité régional de l’Afrique, 60 (AFR/RC60/10, 2011-10-13)
Joint TDR/EC expert consultation on biomarkers in tuberculosis : report of the joint TDR/EC expert consultation to evaluate the potential roles of biomarkers in the management of HIV-infected and HIV-uninfected patients with tuberculosis, Geneva, Switzerland, 2-3 July 2008 / Alimuddin Zumla [...et al.] Zumla, Alimuddin; Wallis, Robert; Klein, Nigel; Oleson, Ole; Lang, Hannu; Vahedi, Mahnaz; Onyebujoh, Philip; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (2009)